October 22nd, 2026
11 a.m. EDT

Psychedelic clinical trials present unique challenges that can make successful execution fundamentally different from small molecules. The psychedelic experience, blinding, psychotherapy assistance, and previous use, for example, introduce complexity that sponsors need to address early in the development process. Experienced cross-functional teams and sites with the right medical expertise, infrastructure, and capabilities can help sponsors navigate these challenges.

In this webinar, a CRO and a site network will share complementary perspectives on what it takes to successfully design and execute psychedelic trials. The discussion will focus on three critical areas: translating the unique characteristics of psychedelics into thoughtful trial design, operationalizing complex studies at the site level, and developing assessment strategies that support reliable and meaningful data. By bringing these perspectives together, the webinar will highlight strategies for anticipating challenges, strengthening study execution, and building effective partnerships from the outset.

Ultimately, successful psychedelic development depends not only on a well-designed protocol, but on early collaboration with experienced partners who understand how to bring that protocol to life.

Attendees will gain insights into:

Translating the unique challenges of psychedelics into effective trial design
Strategies for successfully executing complex studies at the site level
Approaches to assessment and data collection that support reliable results
How early collaboration with experienced partners can strengthen trial execution